Antitrichomonal activity of alpha-difluoromethylornithine. 1987

A F Bremner, and G H Coombs, and M J North
Department of Zoology, University of Glasgow, Scotland.

alpha-Difluoromethylornithine, an inhibitor of polyamine biosynthesis, affected the pathogenicity of Trichomonas vaginalis in two model systems. Firstly, it blocked the cytotoxic effect of the parasite towards mammalian cells in culture: at a concentration of 1 mM it prevented the death of mouse myeloma cells in mixed culture with trichomonads. Secondly, when administered orally to mice (multiple doses of 750 mg/kg body wt), the drug delayed the development of subcutaneous abscesses due to T. vaginalis infection. The same drug dose did not cure intravaginal infections by the parasite. The implications of these findings with respect to the value of the model systems used and the potential of DFMO as an antitrichomonal drug are discussed.

UI MeSH Term Description Entries
D005260 Female Females
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000518 Eflornithine An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway. Difluoromethylornithine,alpha-Difluoromethylornithine,DL-alpha-Difluoromethylornithine,Eflornithine Hydrochloride,Eflornithine Monohydrochloride, Monohydrate,MDL-71,782 A,Ornidyl,RMI 71782,Vaniqa,alpha-Difluoromethyl Ornithine,DL alpha Difluoromethylornithine,MDL 71,782 A,MDL71,782 A,Ornithine, alpha-Difluoromethyl,alpha Difluoromethyl Ornithine,alpha Difluoromethylornithine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000994 Antitrichomonal Agents Agents used to treat trichomonas infections. Antitrichomonal Drugs,Antitrichomonals,Trichomonicides,Agents, Antitrichomonal,Drugs, Antitrichomonal
D014246 Trichomonas vaginalis A species of TRICHOMONAS that produces a refractory vaginal discharge in females, as well as bladder and urethral infections in males. Trichomonas vaginali,vaginali, Trichomonas
D014247 Trichomonas Vaginitis Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS. Trichomoniasis, Human,Human Trichomoniases,Human Trichomoniasis,Trichomonas Vaginitides,Trichomoniases, Human,Vaginitides, Trichomonas,Vaginitis, Trichomonas
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

A F Bremner, and G H Coombs, and M J North
February 1955, The Journal of pharmacy and pharmacology,
A F Bremner, and G H Coombs, and M J North
August 1992, Biochemical and biophysical research communications,
A F Bremner, and G H Coombs, and M J North
January 1964, The Indian journal of medical research,
A F Bremner, and G H Coombs, and M J North
September 1985, Cancer letters,
A F Bremner, and G H Coombs, and M J North
April 1988, The Journal of antibiotics,
A F Bremner, and G H Coombs, and M J North
July 1963, Antibiotiki,
A F Bremner, and G H Coombs, and M J North
August 1991, American journal of clinical oncology,
A F Bremner, and G H Coombs, and M J North
December 1987, Biochemical pharmacology,
A F Bremner, and G H Coombs, and M J North
July 1985, Biochemical pharmacology,
A F Bremner, and G H Coombs, and M J North
November 1985, Journal of medicinal chemistry,
Copied contents to your clipboard!